Product Description:
Xamicare TA (Tranexamic acid) has emerged as a promising topical treatment for various forms of skin discoloration. Studies indicate that its performance is comparable to the widely regarded hydroquinone, and it has shown encouraging results even for persistent issues like melasma. Impressively, close to 96% of individuals in clinical trials experienced visible improvements after 12 weeks of consistent application, particularly when used alongside a broad-spectrum sunscreen—an essential step to prevent further pigmentation.
Application: It is used for Skin-Brightening and anti-Hyperpigmentation effects.
Storage: Keep it in tight, light-resistant containers, in a dry and cool area.
Dosage: 2.0% – 3.0% (Note: The text contains a typo “210%”, likely intended to be 2.0% based on standard cosmetic use for this ingredient).
Shelf time: 2 years from manufacturing date
